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Background: Hydrocarbon alkanes have been recently considered as important next-generation biofuels because
microbial production of alkane biofuels was demonstrated. However, the toxicity of alkanes to microbial hosts can
possibly be a bottleneck for high productivity of alkane biofuels. To tackle this toxicity issue, it is essential to
understand molecular mechanisms of interactions between alkanes and microbial hosts, and to harness these
mechanisms to develop microbial host strains with improved tolerance against alkanes. In this study, we aimed to
improve the tolerance of Saccharomyces cerevisiae, a model eukaryotic host of industrial significance, to alkane
biofuels by exploiting cellular mechanisms underlying alkane response.
Results: To this end, we first confirmed that nonane (C9), decane (C10), and undecane (C11) were significantly toxic
and accumulated in S. cerevisiae. Transcriptome analyses suggested that C9 and C10 induced a range of cellular
mechanisms such as efflux pumps, membrane modification, radical detoxification, and energy supply. Since efflux
pumps could possibly aid in alkane secretion, thereby reducing the cytotoxicity, we formed the hypothesis that
those induced efflux pumps could contribute to alkane export and tolerance. In support of this hypothesis, we
demonstrated the roles of the efflux pumps Snq2p and Pdr5p in reducing intracellular levels of C10 and C11, as
well as enhancing tolerance levels against C10 and C11. This result provided the evidence that Snq2p and Pdr5p
were associated with alkane export and tolerance in S. cerevisiae.
Conclusions: Here, we investigated the cellular mechanisms of S. cerevisiae response to alkane biofuels at a systems
level through transcriptome analyses. Based on these mechanisms, we identified efflux pumps involved in alkane
export and tolerance in S. cerevisiae. We believe that the results here provide valuable insights into designing
microbial engineering strategies to improve cellular tolerance for highly efficient alkane biofuel production.
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Next-generation biofuels, such as long-chain alcohols, and
fatty-acid- and isoprenoid-derived fuels, offer advantages
of high energy density, low freezing point, and compatibil-
ity with the existing fuel storage and distribution infra-
structure [1-4]. Recently, hydrocarbon alkanes, main
components of fossil fuels, have been considered as im-
portant next-generation biofuels because their microbial
production was demonstrated. Schirmer et al. converted
intermediates of fatty acid metabolism to alkanes in* Correspondence: Matthewchang@ntu.edu.sg
School of Chemical and Biomedical Engineering, Nanyang Technological
University, 62 Nanyang Drive, Nanyang 637459, Singapore
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reproduction in any medium, provided the orEscherichia coli by introducing two enzymes involved in
an alkane biosynthesis pathway from cyanobacteria [5].
Bernard et al. identified Arabidopsis alkane synthesis en-
zymatic components and reconstituted plant alkane bio-
synthesis in yeast [6].
Despite these successes in microbial alkane production,
the toxicity of alkanes to microbial hosts can eventually be a
bottleneck for high productivity. To overcome this toxicity
issue, it is imperative to develop engineering strategies to
improve microbial tolerance against biofuel alkanes, which
requires a clear understanding of molecular mechanisms of
interaction between microbial hosts and alkanes. Physiolo-
gically, hydrocarbon accumulation in cell membrane causes
loss of membrane integrity and function, which ultimatelyd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Viability and membrane permeability of S. cerevisiae
cells under exposure to C9-C12. The viability (A) and membrane
permeability (B) were measured upon exposure to alkanes
(2% each) for 48 h. RFU, relative fluorescence unit. Error bars
represent standard deviations from four biological replicates.
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against the toxicity of hydrocarbons by ordering the lipid bi-
layer to modify lipopolysaccharide (LPS) and cell wall/S-
layer hydrophobicity, as well as activating the excretion by
energy-consuming transport systems [8]. Despite the afore-
mentioned studies, which primarily focused on physiological
or cytological effects, there is lack of understanding of the
molecular mechanisms of interactions between microbes
and alkanes especially at a systems level.
Toxicogenomics, which combines genomics and toxi-
cology, is useful for identification of toxicants and their
putative mechanisms of action at a systems level. Re-
cently, toxicogenomics has been applied to elucidate
mechanisms underlying environment stresses and chem-
ical toxicity to microorganisms [9,10]. For instance,
Chang et al. studied the toxicogenomic response of path-
ogens to antimicrobials by using microarray-based tran-
scriptome analyses [11]. Carvalho et al. studied
transcriptomic response in marine diatom Thalassiosira
pseudonana exposed to benzo[a]pyrene [12]. Notably,
toxicogenomics has also offered an effective means to
study the molecular mechanisms of cell response to or-
ganic solvents. For example, based on genome-wide
microarray analyses, our group previously identified and
reconstituted genetic regulatory networks to improve
the tolerance of E. coli against isooctane [13]. In Saccha-
romyces cerevisiae strain KK-211, genes involved in tol-
erance to organic solvents were successfully identified
based on transcriptome analyses [14,15]. Note that S.
cerevisiae, an established and widely used eukaryotic
model for molecular and cellular biology studies, has
been used as an experimental model in toxicogenomics
[16-18]. In this light, this study aimed to (i) investigate
molecular mechanisms underlying cellular response to
alkanes at the systems level and (ii) improve cellular tol-
erance based on these mechanisms in S. cerevisiae, a
model eukaryotic host of industrial significance. Briefly,
we showed that nonane (C9) and decane (C10) induced
cellular mechanisms associated with efflux pumps, mem-
brane modification, radical detoxification, and energy
supply. More importantly, based on these cellular mech-
anisms, we demonstrated that efflux pumps Snq2p and
Pdr5p played roles in reducing intracellular levels of C10
and undecane (C11), and enhancing tolerance levels
against C10 and C11. Given the aforementioned recent
reports on microbial alkane production [5,19], we envi-
sion that the engineering strategy established in this
study can readily be extended to develop robust micro-
bial hosts for alkane biofuels production.
Results and discussion
Toxicity and intracellular accumulation of alkanes
We first examined the toxicity of nonane (C9), decane
(C10), undecane (C11), and dodecane (C12). In thiswork, we primarily focused on C9-C12 because our pre-
liminary studies had indicated low cytotoxicity of C13
and longer alkanes. S. cerevisiae BY4741 cells were incu-
bated in the medium containing each alkane (2% [v/v]).
Figure 1A shows that cell viability was decreased upon
exposure to C9-C12. In particular, treatment with C9-
C11 decreased cell viability by about 50%. Based on this
result, we hypothesized that C9-C12 might affect cell
membrane permeability or integrity. Figure 1B shows
that the intensity of red fluorescent signal of propidium
iodide (PI) and the ratio of the fluorescent signals (PI/
SYTO9) were increased upon exposure to C9-C12. If
more PI molecules penetrate into cell wall/membrane
and stain nucleic acids, PI intensities and PI/SYTO 9 ra-
tios become higher. Therefore, this result suggests that
C9-C11 increased cell membrane permeability. Among
these alkanes, C9 and C10 resulted in the highest PI in-
tensities and PI/SYTO9 ratios, which indicates the
highest membrane permeability. To determine whether
this increased membrane permeability was contributed
by damage on cell surface, cell surface was examined
using Field Emission Scanning Electron Microscopy
(FESEM). As shown in Additional file 1: Figure S1,
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to 2% C9, which is in agreement with de Smet and co-
workers’ study [20]. Based on this result, we hypothe-
sized that alkane toxicity might be attributed at least
partly to intracellular accumulation. GC analyses show
that a peak corresponding to each alkane was detected
from alkanes-treated cells, while control cells without
alkanes exhibited a negative signal (Additional file 2:
Figure S2). To measure intracellular alkane amounts, we
normalized GC peak areas to the internal standard and
the total protein amount. Among C9 to C12, C10
showed the highest intracellular level, followed by C9
and C11, and C12 level was the lowest which was 90%
lower than C10 level (Figure 2). These results indicate
that alkanes were accumulated in cells, which likely con-
tributed to alkane toxicity. According to Inoue and
Kawamoto [21,22], toxicity of a compound is related to
coefficient of octanol-water partition (log Pow). Gill and
coworkers reported that higher aliphatic chain alkanes
tend to show lower toxicity [23]. In our study, C12 (log
Pow 7.0) showed lower toxicity than C9 to C11 (log Pow
<6.0), which could be partially due to low accumulation
of C12 in S. cerevisiae.
Genome-wide gene expression profiles upon exposure to
biofuel alkanes
To understand cellular mechanisms underlying S.
cerevisiae response to C9-12, transcriptome profiles were
generated using whole-genome S. cerevisiae microarrays.
Significantly regulated genes (fold changes ≥ 2.0, andFigure 2 GC analyses of intracellular alkanes in S. cerevisiae.
Cells were exposed to 2% of each n-alkane for 48 h. Intracellular
alkanes were measured by GC and normalized to the total protein
amount and the internal standard n-tridecane. A.U., arbitrary unit.
Error bars represent standard deviations from three
biological replicates.p values < 0.05) are summarized in Additional file 3. The
data discussed in this publication have been deposited in
NCBI’s Gene Expression Omnibus and are accessible
through GEO Series accession number GSE38653. In
addition, quantitative PCR (qPCR) was carried out to
validate the microarray data (Additional file 3).
Our transcriptome analysis indicated that 526 (C10 for
24 h), 692 (C9 for 48 h), 428 (C10 for 48 h), and 119
(C11 for 48 h) genes were differentially regulated, while
5 (24 h) and 8 (48 h) genes were regulated by C12
(Additional file 3). Functional analysis of those genes
suggested that C11 primarily regulated genes related to
heat shock response and sugar transport, whereas C9
and C10 induced a range of similar groups of genes.
Therefore, to look into cellular mechanisms commonly
stimulated by alkanes, we analyzed the genes regulated
by both C9 and C10. 147 genes were significantly regu-
lated by both C9 and C10. Among the 147 genes, 105
genes were induced by both C9 and C10, whereas 42
genes were repressed by both C9 and C10 (except for
COS12 gene which was down-regulated by C10 but up-
regulated by C9). To further understand gene functions,
we functionally classified the aforementioned regulated
genes using MIPS tools (http://funspec.med.utoronto.ca/)
[24]. Primary functional classes of the regulated genes
were (i) efflux pumps, (ii) stress response, (iii) fatty acid,
lipid, and derivatives biosynthesis, and (iv) hexose trans-
port, ergosterol biosynthesis, and thiamine biosynthesis
(Table 1). The genes in these classes were mostly induced
by C9 and C10.
First of all, notably, four plasma membrane efflux
pump genes YOR1, SNQ2, PDR5, and PDR15 were sig-
nificantly induced by alkane stress. Plasma membrane
efflux pumps recognize and extrude a large spectrum of
functionally and structurally unrelated drugs such as
oligomycin, mycotoxins, and anticancer drugs [25-28].
That is, when cytotoxic compounds cross the plasma
membrane to enter cells, a number of efflux pumps help
to protect cells from unwanted or damaging xenobiotics.
According to Ernst and coworkers [29], efflux pumps
serve as a defense line mediating pleiotropic drug resist-
ance (PDR). Therefore, the result that efflux pump genes
were significantly induced here suggested that they
might also provide protection to the cells against
alkanes.
Other than efflux pump genes, genes involved in stress
response for radical detoxification, fatty acid and lipid
synthesis, and hexose transport were also induced by al-
kanes. For example, GRE genes associated with multiple
stresses [30] and heat shock protein gene HSP12 were
induced up to 16-fold, and fatty acid synthase genes
FAS1 and FAS2 were induced over 4-fold. Acetyl-CoA
carboxylase gene ACC1 was up-regulated about 6-fold.
Acc1p is a biotin-containing enzyme that participates
Table 1 MIPS functional classification of genes
differentially regulated by both C9 and C10
Functional category k f
Up-regulated
fatty acid metabolism 5 24
phospholipid metabolism 7 68
oxidative stress response 6 55
tetracyclic and pentacyclic triterpenes 5 36
cellular import 7 90
lipid/fatty acid transport 5 44
ABC transporters 4 28
lipid, fatty acid and isoprenoid metabolism 8 133
degradation of glutamate 2 4
metabolism of amino acid-derived secondary products 2 4
NAD/NADP binding 4 36
C-compound and carbohydrate metabolism 10 223
heat shock response 3 20
chemical agent resistance 3 22
S-adenosyl-methionine-homocysteine cycle 2 7
pH stress response 2 8
oxidation of fatty acids 2 9
transport ATPases 4 53
Down-regulated
biosynthesis of thiamine 6 110
transport facilities 5 87
degradation of lysine 2 5
degradation of glycine 2 6
transport routes 2 11
metabolism of thiamine 3 43
tetrahydrofolate-dependent C-1-transfer 2 13
Note: functional classification was generated by the online program FunSpec
(http://funspec.med.utoronto.ca/) with p-value cut-off of 0.01. k, number of
genes from the input (105 up-regulated genes, and 42 down-regulated genes)
in the given category, f, number of genes total in the given category.
Table 2 Transcription factors with activity changes,
predicted by Network Component Analysis (NCA)
Transcription factors Regulatory activity
C10-24 h C10-48 h C9-48 h
YKL112W ABF1 +3 +3 +3
YKR099W BAS1 +3 +3 +4
YDR123C INO2 +12 +18 +19
YOL108C INO4 +3 +4 +3
YGL162W SUT1 +4 +5 +5
YDR207C UME6 +6 +4 +4
YOR028C CIN5 −2 −3 −10
YPR104C FHL1 −3 −4 −8
YLR256W HAP1 −3 −3 −7
Note: C10-24 h, cells exposed to C10 for 24 h compared to cells without
alkane exposure for 24 h, C9- or C10-48 h, cells exposed to C9 or C10 for 48 h
compared to cells without alkane exposure for 48 h. +, upregulation,
-, downregulation.
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malonyl-CoA, which is a rate-limiting step in the fatty
acid synthesis pathway [31]. In addition, INO1 gene was
induced over 50-fold, which is associated with synthesis
of phosphatidylinositol by using glucose-6-P and CDP-
DAG as precursors [32].
Upon alkanes exposure, six transcription factor genes,
ASH1, GAL4, NRG2, MGA2, YPR015C, and THI2, were
differentially regulated. Because changes in gene expres-
sion levels of transcription factors frequently do not cor-
relate with changes in their regulatory activities, to
further identify transcription factors with perturbed
regulatory activities under alkane exposure, we analyzed
our transcriptome data using Network Component Ana-
lysis (NCA). NCA is an algorithm that calculates relative
activities of transcription factors from gene expres-
sion data [13]. NCA results suggested that regulatoryactivities of nine transcription factors were changed
upon exposure to C9 (48 h) and C10 (24 h, and 48 h)
(Table 2). Among the nine transcription factor genes
identified from NCA, the activities of six transcription
factors were increased, and the activities of three were
decreased. To further understand regulatory relation-
ships between transcription factors and the genes in-
volved in C9 and C10 response, a regulation matrix was
generated by YEASTRACT (http://www.yeastract.com/)
[33]. In the generated transcription networks (Figure 3),
INO2 showed regulation of genes associated with efflux
pumps, stress response, lipid metabolism and ergosterol
biosynthesis. Hereby, we predicted that INO2 would
most likely be one of the key transcription factors that
regulate gene networks in response to alkanes exposure
in S. cerevisiae. Further, the three repressed transcription
factors (i.e. CIN5, FHL1, and HAP1) likely up-regulate
their target genes such as GRE2, GND2, and ERG6
(Figure 3). Therefore, there is a possibility that the afore-
mentioned transcription factors induce genes associated
with efflux pumps, stress response, and lipid metabolism
in S. cerevisiae upon exposure to both C9 and C10.
Based on our transcriptome data, and the functions
and physiological roles of the regulated genes, we hy-
pothesized that S. cerevisiae responded to alkanes
stresses through integrative mechanisms (depicted in
Figure 4). First, efflux pump genes (YOR1, SNQ2, PDR5,
and PDR15) are induced to export intracellular alkanes
to reduce alkane toxicity. Second, alkanes exposure gen-
erates radicals and induces stress-responsive genes to-
wards radical detoxification. Alkane molecules penetrate
cell wall, disperse into cytoplasmic membrane, and gen-
erate radicals (e.g. reactive oxygen species (ROS), and
NO), while stress-responsive genes (GRE1, GRE2, CTT1,
HSP12, TSA2, and YHB1) are induced to detoxify radi-
cals including ROS. Notably, in line with this hypothesis,
Figure 3 The predicted transcription regulatory network. Regulation matrices were generated by YEASTRACT (http://www.yeastract.com/)
based on the documented regulations, with our transcription factors as regulator candidates and regulated genes as target candidates.
Transcription factors are shown in a grey box, and target genes are in an open box. Genes regulated by the same transcription factor in each
group are shown with arrows in the same color.
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and 78% in S. cerevisiae upon exposure to C9 and C10,
respectively (Additional file 3). Such increase in ROS
levels is most likely correlated with alkanes toxicity.
Third, more energy sources are generated through accel-
eration of glucose and fatty acid metabolism. Hexose
transport genes (HXT5, HXT6, and HXT7) are induced
to increase glucose import. Thereafter, energy sources
(FADH, NADH, NADPH, and ATP) are enriched
through enhanced glucose metabolism involving pentoseFigure 4 Schematic representation of hypothesized mechanisms of ce
alkane efflux (blue), detoxification of radicals (green), energy supply (red), aphosphate pathway (GND2), β-oxidation of fatty acids
(FAA4, and POT1), and ALD3-involved pathways. ATP
may be used for alkanes export by efflux pumps. Fourth,
the increase in glucose import and consumption aids in
modifying membrane components (i.e. lipid, and ergos-
terol), thereby helping cells to adapt to alkanes exposure.
Enriched glucose inside the cells may lead to the synthe-
sis of more fatty acids, lipids, and derivatives (i.e.
phospholipid, glycerophospholipid, phosphatidylinositol,
and phosphatidylcholine), contributed to by such inducedllular response to alkanes in S. cerevisiae. The mechanisms include
nd membrane modification (purple).
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INO1, ITR1, and OPI3. Further, ergosterol biosynthesis is
enhanced by the four induced genes HMG1, EGR3, ERG6,
and ERG25. Such a change in the expression of genes in-
volved in lipid and ergosteols metabolism may lead to
membrane modification, possibly facilitating adaptation to
alkanes exposure.
Overexpression of efflux pumps leads to improved
tolerance to biofuel alkanes
Among the aforementioned mechanisms, we were inter-
ested in further identifying roles of plasma membrane
efflux pumps in alkane tolerance and export because (i)
plasma membrane efflux pumps are the first line of
defense against drugs or organics, and (ii) microbial ef-
flux pumps reportedly serve as a direct mechanism to
improve biofuel tolerance [4,34-37] as well as productiv-
ity [4]. In fungi, efflux pumps, especially ATP-binding
cassette (ABC) efflux pumps (e.g. Pdr5p and Snq2p in S.
cerevisiae, Cdr1p and Cdr2p in Candida albicans),
which contribute to multidrug efflux resistance, have
been most extensively studied [25-28,38]. In our study,
all the four efflux pumps induced by alkanes are ABC
transporters, and considered as major pleiotropic drug
transporters that comprise a PDR network in yeast [39].
Among them, Snq2p, Pdr5p, and Pdr15p belong to a
pleiotropic drug resistance (PDR) protein subfamily, and
Yor1p belongs to a multidrug resistance-associated pro-
tein (MRP) subfamily. Their protein architecture con-
tains multiple transmembrane domains (TMDs) that
bind chemical compound and provide a translocation
channel, and nucleotide-binding domains (NBDs) that
couple ATP hydrolysis to substrate transport. Given
that the induced ABC efflux pumps play roles in re-
ducing intracellular alkane accumulation, tolerance of
S. cerevisiae cells against alkanes could be improved.
Hence, we formed a hypothesis that the significantly in-
duced efflux pumps might also help cells to reduce the
intracellular alkane accumulation and thus, provide pro-
tection to cells against alkanes.
To identify roles of each of the induced efflux pumps
in reducing intracellular alkane levels and improving al-
kane tolerance levels, we constructed triple knock-out
mutants of efflux pumps, BYL251K (yor1Δ snq2Δ pdr5Δ)
and BYL2515K (snq2Δ pdr5Δ pdr15Δ). Subsequently, we
cloned the four efflux pump genes (YOR1, SNQ2, PDR5,
and PDR15) into plasmid pYES2 respectively, and
transformed recombinant plasmids into the triple mu-
tants. Under control of the galactose-inducible promoter
PGAL1 and exposure to alkanes, the aforementioned ef-
flux pump genes (YOR1, SNQ2, and PDR5) were
expressed in the triple mutant BYL251K respectively,
and PDR15 was expressed in the triple mutant
BYL2515K. Cell tolerance and intracellular alkane levelswere then analyzed (Figure 5, and Additional file 4:
Figure S3). Figure 5A shows that there was similar
growth among the BYL251K cells with pYES2 (control)
and with SNQ2 or PDR5 in an alkane-free induction
medium. Upon exposure to C10, cell growth of the triple
mutant BYL251K expressing each of Snq2p and Pdr5p
was significantly enhanced, compared to BYL251K with
the plasmid pYES2 (Figure 5B). This result suggested
that expression of Snq2p and Pdr5p, respectively, in-
creased cellular tolerance to C10. Furthermore, Figure 5C
shows that upon 24 h exposure to C10, intracellular C10
amount was lowered by 25% and 33% in the triple mu-
tant BYL251K expressing either Snq2p or Pdr5p. This
result indicated a crucial role of Pdr5p and Snq2p in re-
ducing the intracellular C10 levels, consistent with the
hypothesis on the role of efflux pumps in improving al-
kane tolerance as mentioned above. Furthermore, we
tested growth of cells expressing Pdr5p and Snq2, re-
spectively, under 5% C11. In support of our hypothesis,
the triple knock-out mutant BYL251K expressing the ef-
flux pump Snq2p or Pdr5p showed much higher cell
density than the control cells, even though C11 did not
induce expression of those efflux pumps according to
our microarray data. This result suggested that tolerance
to C11 was significantly improved by the efflux pumps
Snq2p and Pdr5p. Further, Figure 5C shows that intra-
cellular C11 levels were lowered by 87.4% and 94.4% in
the triple mutant BYL251K expressing Snq2p and Pdr5p,
respectively. This result indicated a crucial role of Pdr5p
and Snq2p in reducing the intracellular C11 levels, con-
sistent with the aforementioned hypothesis on the role
of efflux pumps in improving the tolerance to C11. Note
that the Resistance-Nodulation-Division (RND) efflux
pumps such as AcrAB-TolC pump, Mex pumps, Ttg
pumps from Gram-negative bacteria have been previ-
ously studied as an effort to improve tolerance to
biofuels in bacteria [34,35,37,40]. However, the RND
pumps utilize proton or sodium gradients as a source of
energy [41,42] instead of ATP by ABC efflux pumps.
This suggests that yeast and gram-negative bacteria em-
ploy different types of efflux pumps for improving the
biofuel tolerance.
However, even though the efflux pump genes (YOR1,
SNQ2, PDR5, and PDR15) were all induced by both C9
and C10 according to our microarray data (Additional
file 3), there was no improvement in tolerance against
C9 by complementation of each of the four efflux
pumps. In addition, there was no improvement in toler-
ance against C10 and C11 by complementation of Yor1p
or Pdr15p. This outcome was probably due to variance
in substrate binding efficacy of various efflux pumps,
and/or the involvement of such mechanisms as stress re-
sponse and membrane modification, in addition to efflux
pumps, in cellular tolerance to C9. Engineering
Figure 5 Growth of triple knock-out mutants expressing efflux pumps and their intracellular alkane levels under alkane exposure. The
triple mutant BYL251K (yor1Δ snq2Δ pdr5Δ) expressing Snq2p and Pdr5p, respectively, were grown in induction media without alkanes (A) or with
2% C10 or 5% C11 (B). OD600 values represent cell density. After 24 h exposure, intracellular C10 and C11 levels were measured by GC and
normalized to the total protein amount and the internal standard C12 (C). Alkane amount in control cells was set as 1. Control, the triple mutant
BYL251K with pYES2. Error bars represent standard derivations of at least three biological replicates. *, statistically significant difference (Student t-
test, p < 0.05) compared to cells with pYES2.
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ing, and gene shuffling can be employed to improve sub-
strate binding efficacy [10,43-45]. Other than the
indigenous efflux pumps in S. cerevisiae, efflux pumps
from other microbes can also be introduced to improve
tolerance against biofuel alkanes. In addition, future
studies could include use of other cellular mechanisms
besides efflux pumps as an effort to improve alkane
tolerance.
Conclusions
To our knowledge, this is the first report providing the
evidence of the direct linkage between alkane tolerance
and indigenous efflux pumps, and of being able to de-
velop alkane-tolerant S. cerevisiae by directly harnessing
indigenous efflux pumps. Herein, we first confirmed that
C9, C10, and C11 were significantly toxic and accumu-
lated in S. cerevisiae. Transcriptome analyses suggested
that C9 and C10 induced a range of cellular mechanisms
such as efflux pumps, membrane modification, radical
detoxification, and energy supply. Since efflux pumps
could possibly aid in alkane export, thereby reducing thecytotoxicity, we formed the hypothesis that those in-
duced efflux pumps could contribute to alkane toler-
ance. In support of this hypothesis, we demonstrated the
roles of the efflux pumps Snq2p and Pdr5p in reducing
the intracellular levels of C10 and C11, and enhancing
the tolerance levels against C10 and C11. This result
provided the evidence that Snq2p and Pdr5p were asso-
ciated with alkane export and tolerance in S. cerevisiae.
We believe that the results here provide valuable in-
sights into designing microbial engineering strategies to
improve cellular tolerance for highly efficient alkane bio-
fuel production.
Methods
Strains, chemicals and plasmids
S. cerevisiae BY4741 (MATa; his3 Δ1; leu2Δ0; met15Δ0;
ura3Δ0) was obtained from ATCC (American Type Cul-
ture Collection), and gene deletion mutants were
constructed in this study (Additional file 3). Yeast
extract and peptone were obtained from BD (NJ, USA).
Alkanes and other chemicals were obtained from Sigma-
Aldrich unless specifically mentioned. pUG6 and pSH47
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cells. Plasmid pYES2 (Invitrogen, Grand Island, NY,
USA) was used for gene expression in yeast cells. E. coli
Top10 was used for gene cloning.
Growth conditions
S. cerevisiae strains were grown in YPD medium (Yeast
extract 10 g/l, Peptone 20 g/l, and D-Glucose 20 g/l),
minimum medium (Yeast Nitrogen Base 6.7 g/l, D-
Glucose 20 g/l, L-Leucine 0.2 g/l, Uracil 0.1 g/l, 2% n-
alkanes; Yeast Nitrogen Base 6.7 g/l, D-Glucose 20 g/l,
Yeast Synthetic Drop-out Medium Supplements-Ura-
1.92 g/l), or induction medium (Yeast Nitrogen Base
6.7 g/l, Raffinose 10 g/l, Galactose 20 g/l, and Yeast Syn-
thetic Drop-out Medium Supplements-Ura- 1.92 g/l) at
appropriate temperatures. E. coli cells were grown in LB
broth at 37°C. Geneticin G418 (PAA Laboratories
GmbH, AT) or Ampicillin was used at 200 μg/ml and
100 μg/ml, respectively.
Cell viability, membrane integrity and reactive oxygen
species (ROS)
S. cerevisiae BY4741 cells were grown overnight in YPD,
diluted into minimal medium with amino acids which
contains each of 2% alkanes (C9-C12) with an initial
OD600 of 0.2, and followed by shaking incubation at
28°C, and viable cells measurement by CFU (Colony
Forming Unit) counting. To investigate whether these al-
kanes resulted in membrane damage, membrane perme-
ability was analyzed by cell staining. After exposure to
alkanes, cells were stained with fluorescent nucleic acid
stains SYTO 9 and propidium iodide (PI) (Invitrogen)
that only penetrates cells with damaged membrane. Fi-
nally, signal intensity in cells was measured using Syn-
ergy HT multi-mode microplate reader (Biotek, VT,
USA) at wavelength of 485/20 nm (excitation), 528/
20 nm (SYTO 9 emission), and 645/40 nm (PI emission).
To investigate reactive oxygen species (ROS) generation,
alkane-treated cells were collected and stained by
CellROXW Green Reagent (Life Technologies). Fluores-
cence signals were measured by TECAN Infinite 200
microplate reader at wavelength of 485 nm (excitation)/
535 nm (emission) and normalized to cell density
(OD600).
Alkane extraction and detection
Alkanes were extracted by chloroform-methanol extrac-
tion method [46] with modifications. Firstly, yeast cells
were collected and washed with 50 mM Tris.Cl (pH 7.4)
then resuspended in 0.4 ml chloroform/methanol mix-
ture (v/v: 2/1). Subsequently, 0.3 g acid-washed glass
beads (425-600 μm, Sigma-Aldrich) were added into
each sample and cells were lysed using FastPrep-24 (MP
Biomedicals, Solon, OH, USA). Then, after the lysatewas centrifuged at 4°C at maximum speed for 10 min,
an appropriate volume of chloroform and 50 mM Tris.
Cl were added to the supernatant for extraction. Finally,
the chloroform phase with alkanes was transferred into
glass vials for Gas Chromatography (GC) analysis. This
was performed using Agilent GC 7890A system (Agilent
Technologies, Santa Clara, CA, USA) under the follow-
ing conditions. With Agilent HP-5 GC column, oven
temperature was started at 40°C for 30 sec, and was
ramped from 40°C to 220°C at 40°C/min, and FID de-
tector temperature remained at 275°C. A mixture of n-
alkanes (10 ppm each) was used as the standard for GC
analysis.
RNA preparation, transcriptome analysis, and quantitative
PCR
Total RNA was extracted with lyticase for cell wall dis-
ruption using RNeasy Mini Kit (Qiagen, Hilden,
Germany). Total RNA concentration and integrity were
measured using NanoDrop (Thermo Scientific, Wilmington,
DE, USA) and Agilent Bioanalyzer 2100, respectively. Subse-
quently, 200 ng of the qualified total RNA was transcribed
and labeled using Agilent RNA Spike-in Kit and Low Input
Quick Amp Labeling Kit (two colors). The Cy3- or
Cy5-labeled cRNA was hybridized onto Yeast (V2) Gene
Expression Microarray (8 × 15 K) at 65°C for 17 h, using
Agilent GE Hybridization Kit. Thereafter, the microarray
slide was scanned using Agilent Microarray Scanner
G2505B. The two-color scanning data were extracted using
Agilent Feature Extraction software (v10.5) and analyzed
using GeneSpring GX 11. From two biological replicates,
differentially expressed genes were selected based on their p
values (<0.05, t-test) and fold changes (FC) in n-alkane-
treated cells in comparison to control cells (≥2.0).
To validate the microarray data, quantitative PCR
(qPCR) was performed with primers targeting the se-
lected genes (Additional file 3) and SsoFast™ EvaGreenW
Supermix using iQ5 real-time PCR detection system
(Bio-Rad). The qPCR data analysis was conducted with
ACT1 as a reference gene using Bio-Rad iQ5 optical
system software.
Network component analysis (NCA)
The Network Component Analysis is an algorithm that
calculates relative activities of transcription factors from
gene expression data [13]. In brief, a matrix of gene
expression data ([E]), which contain genes in rows and
experimental conditions in columns, are prepared for
NCA analysis. Subsequently, the [E] matrix is decomposed
into two matrices, a connectivity strength (CS) matrix
([A]) with transcription factors (columns) and genes
(rows) and a transcription factor activity (TFA) matrix
([P]) with transcription factors (rows) an experimental
conditions (columns). In our study, to perform NCA
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([E]) were built from 147 genes (fold changes ≥ 2.0, and
p values < 0.05), up- or down-regulated under the three
conditions (C10 vs. control at 24 h and 48 h, and C9 vs.
control at 48 h); second, the connectivity strength (CS)
matrix [A] from Lee and coworkers [47] was used to
primarily define connectivity relations between the genes
and the transcription factors; third, the final TFA matrix
[P] was deduced by NCA.
Yeast gene deletion
Gene deletion was carried out as previously described [48].
Briefly, loxP-Kan-loxP gene disruption cassettes were ampli-
fied using PCR with primers as shown in Additional file 3
and pUG6 as the template, which were then purified using
QIAquick Gel Extraction Kit (Qiagen). The purified
cassettes were used for yeast transformation as previously
described. The colonies were screened on YPD plates
containing 200 μg/ml G418 and confirmed by PCR. To per-
form marker rescue, pSH47 was transformed into mutants,
selected on minimal medium (Ura-) plates, and followed by
Cre/loxP-mediated marker removal in induction medium.
Finally, selection for the loss of marker was performed in
YPD containing 1 mg/ml 5-fluoro-orotic acid (Thermo
Scientific).
Plasmid construction and analyses of yeast strains
overexpressing efflux pump genes
The gene specific primers (Additional file 3) and iProof
High-Fidelity DNA Polymerase (Bio-Rad) were employed
to amplify target genes by PCR with S. cerevisiae BY4741
genomic DNA as a template. DNA fragments were puri-
fied and cloned into an expression vector pYES2. The
recombinant plasmids were prepared using QIAprep
Miniprep Kit (Qiagen), transformed into S. cerevisiae mu-
tants by electroporation [49], and followed by selection on
Geneticin-containing minimal medium plates. To investi-
gate effects of mutants expressing efflux pumps on cell
growth and alkane accumulation, cells harboring a recom-
binant plasmid were grown in an induction medium plus
alkanes. Subsequently, optical density of cells at 600 nm
(OD600) and intracellular alkanes were measured.
Additional files
Additional file 1: Figure S1. Cell morphology of S. cerevisiae BY4741
cells upon exposure to 2% C9. C9-treated cells were collected for FESEM
(Field Emission Scanning Electron Microscopy) analysis after exposure to
C9 for 48 h. For sample preparation, cells were washed with Tris.Cl
(pH 7.4) immediately after alkane treatment, and then fixed in 2%
glutaraldehyde at 4°C for overnight followed by 1% osmium tetroxide for
10 min. Cell samples were dehydrated through ethanol: 2 min in each of
30%, 50%, 70%, 95% (twice) and 100% (three times). Thereafter, cells were
loaded onto silicon slides and dried. Then, samples were coated with
platinum and observed using FESEM JSM-6700 F (JEOL). Control, S.
cerevisiae BY4741 cells in alkane-free medium.Additional file 2: Figure S2. GC chromatograms of alkanes extracted
from S. cerevisiae BY4741 cells. Control, cells without alkanes, IS, internal
standard, C13, n-tridecane. Peaks were indicated by arrows.
Additional file 3: Table S1. List of genes differentially regulated in S.
cerevisiae upon exposure to alkanes. This table contains 7 sub-tables
(A-G): A. Genes differently regulated upon exposure to C10 (24 h, and
48 h) and C9 (48 h); B. C9-48 h; C. C10-24 h; D. C10-48 h; E. C11-48 h; F.
C12-24 h. G. C12-48 h. Table S2. Validation of microarray data by qPCR
upon exposure to C10 for 48 h. Table S3. ROS levels in S. cerevisiae upon
exposure to C9 and C10 for 24 h. Table S4. Yeast strains and plasmids
used in this study. Table S5. Primers used in this study.
Additional file 4: Figure S3. GC chromatograms of C10 and C11 from
S. cerevisiae BYL251K cells. IS, internal standard. Peaks were indicated by
arrows.
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